Lite Strategy LITS
NASDAQ LITS
$0.99 +0.05 (+4.91%)
At close: Aug 21, 2026 · 4:00 PM EDT

Lite Strategy (LITS) Profit After Tax (2010 - 2026)

Lite Strategy (LITS) posted quarterly Profit After Tax of -$23.7 million for Q1 2026, down 820.87% year-over-year from $3.3 million in Q1 2025, and up 23.07% quarter-over-quarter from -$30.8 million in Q4 2025.

Lite Strategy (LITS) Profit After Tax (2010 - 2026) Analysis & Trends

Lite Strategy's Profit After Tax history runs 17 years deep, the most recent figure standing at -$23.7 million for Q1 2026.

  • In Q1 2026, Profit After Tax fell 820.87% year-over-year to -$23.7 million; the TTM figure through Mar 2026 stood at -$60.9 million (down 92.26% YoY), while the FY2025 annual figure was -$16.0 million, down 190.0% from the prior year.
  • Profit After Tax for Q1 2026 stood at -$23.7 million, up from -$30.8 million in the prior quarter.
  • The five-year high for Profit After Tax was $56.4 million in Q3 2023, with the low at -$30.8 million in Q4 2025.
  • The 5-year median for Profit After Tax is -$9.1 million (2024), against an average of -$6.7 million.
  • The sharpest annual moves came in 2023 and 2025: Profit After Tax jumped 439.11% in 2023, then plunged 1050.5% in 2025.
  • Lite Strategy's Profit After Tax stood at $10.3 million in 2022, then tumbled by 207.9% to -$11.1 million in 2023, then jumped by 75.8% to -$2.7 million in 2024, then slumped by 1050.5% to -$30.8 million in 2025, then advanced by 23.07% to -$23.7 million in 2026.
  • Business Quant data shows LITS's Profit After Tax at -$23.7 million in Q1 2026, -$30.8 million in Q4 2025, and -$3.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 472.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -782.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 237.01 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 164.49 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -355.03 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -16.62 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 81.49 Mn
10 Lite Strategy 35.71 Mn 28.17 Mn - -23.69 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -23.69 Mn
Dec 31, 2025 -30.80 Mn
Sep 30, 2025 -3.64 Mn
Jun 30, 2025 -2.74 Mn
Mar 31, 2025 -2.57 Mn
Dec 31, 2024 -2.68 Mn
Sep 30, 2024 -8.01 Mn
Jun 30, 2024 -18.41 Mn
Mar 31, 2024 -9.13 Mn
Dec 31, 2023 -11.06 Mn
Sep 30, 2023 56.37 Mn
Jun 30, 2023 -10.19 Mn
Mar 31, 2023 -15.44 Mn
Dec 31, 2022 10.25 Mn
Sep 30, 2022 -16.62 Mn
Jun 30, 2022 -16.06 Mn
Mar 31, 2022 -8.73 Mn
Dec 31, 2021 -12.16 Mn
Sep 30, 2021 -17.51 Mn
Jun 30, 2021 -8.38 Mn